Skip to main content
Clinical Trials/NCT06677047
NCT06677047
Not Yet Recruiting
N/A

Assessment of Improvement in Functional Status of Patients With Pulmonary Fibrosis After Exercise Rehabilitation Program

Assiut University0 sites60 target enrollmentJanuary 20, 2025
ConditionsRehabilitation

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rehabilitation
Sponsor
Assiut University
Enrollment
60
Primary Endpoint
**Asses Health-Related Quality of Life:**
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition

Detailed Description

program is essential for understanding its efficacy. Functional status refers to an individual's ability to perform daily activities and maintain independence, which is particularly important for patients with chronic illnesses like PF. Evaluating changes in functional status not only helps in determining the success of rehabilitation efforts but also provides insights into the overall impact of exercise on patients' quality of life.

Registry
clinicaltrials.gov
Start Date
January 20, 2025
End Date
August 20, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hend Mohamed Sayed Mohamed

Doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • \*\*Diagnosis of Pulmonary Fibrosis:\*\*
  • Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography).
  • \*\*Age Range:\*\*
  • Participants should be adults aged 18 years and older to capture the adult population affected by the disease.
  • \*\*Stable Clinical Condition:\*\*
  • Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen

Exclusion Criteria

  • \*\*Other Significant Lung Diseases:\*\*
  • Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results.
  • \*\*Acute Exacerbations:\*\*
  • Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment.
  • \*\*Severe Comorbidities:\*\*
  • Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise.
  • \*\*Cognitive Impairment:\*\*
  • Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.

Outcomes

Primary Outcomes

**Asses Health-Related Quality of Life:**

Time Frame: Baseline

Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)

Similar Trials